POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer

<strong>Purpose:</strong> Recent studies have shown that 7-12% of endometrial cancers (ECs) are ultramutated due to mutation in the proofreading exonuclease domain of the DNA replicase POLE. Interestingly, these tumors have an excellent prognosis. In view of the emerging data linking mut...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar:	Klenerman, P, Church, D, Tomlinson, I, van Gool, I, Eggink, F, Freeman-Mills, L, Stelloo, E, Marchi, E, de Bruyn, M, Palles, C, Nout, R, de Kroon, C, Osse, E, Creutzberg, C, Smit, V, Nijman, H, Bosse, T
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	American Association for Cancer Research 2015

POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer

Benzer Materyaller